Population
Vascular smooth muscle cells
Design
Preclinical
Authors
Loading...
Should not alter clinical hypertension management; leaves open translation of IP3-DG crosstalk to human vascular disease.
Angiotensin II stimulation in vascular smooth muscle cells triggers a complex interaction between IP3 and DG second messenger systems to mediate cellular responses.
Griendling et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: